CLRB

Cellectar Biosciences Inc.

Price

$1.44

return (12m)

-68.96%

p/e

-0.78

p/bv

0.58

DIVIDEND YIELD

0.00%

CLRB price

Cellectar Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CLRB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-37.93%

3 months

-45.24%

1 year

-68.96%

2 years

-97.74%

5 years

-99.47%

10 years

-99.98%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CLRB

Valuation

P/E

-0.78

Sector -3.34

Industry -3.34

P/BV

0.58

Sector 1.89

Industry 1.89

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

2.33

Sector -219.22

Industry -219.22

EV/EBIT

2.32

Sector -47.87

Industry -47.87

P/EBITDA

-0.74

Sector -22.33

Industry -22.33

P/EBIT

-0.74

Sector -28.88

Industry -28.88

P/Total Assets

0.47

Sector 1.11

Industry 1.11

P/Net Current Assets

0.62

Sector -9.46

Industry -9.46

P/Working Capital

0.58

Sector -148.60

Industry -148.60

EPS

-1.83

Sector -1.78

Industry -1.78

BVPS

2.44

Sector 1.98

Industry 1.98

Efficiency

Gross Margin

0.00%

Sector 41.35%

Industry 41.35%

EBITDA Margin

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

0.00%

Sector -35.47%

Industry -35.47%

Net Profit Margins

0.00%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-74.73%

Sector -57.36%

Industry -57.36%

ROA

-60.93%

Sector -59.44%

Industry -59.44%

ROIC

-1,522.16%

Sector -2,371.18%

Industry -2,371.18%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.66

Sector 2.91

Industry 2.91

Net Debt / EBITDA

4.75

Sector -21.45

Industry -21.45

Net Debt / EBIT

4.72

Sector -8.32

Industry -8.32

Net Debt / Equity

-1.14

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.82

Sector 0.46

Industry 0.46

Liabilities/Assets

0.18

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-1.54%

Sector -

Industry -

Fundamentals CLRB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CLRB Cellectar Biosciences Inc.	$1.44	-68.96%	0.00%	-0.78	0.58	-74.73%	0.00%
PFE Pfizer Inc.	$28.25	23.91%	6.23%	36.34	1.84	5.07%	6.80%
ABBV AbbVie Inc.	$276.61	23.83%	2.47%	77.50	-82.49	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.20	-30.25%	4.83%	9.39	4.99	53.11%	35.32%
MRK Merck & Co. Inc.	$142.71	70.83%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$157.00	-5.51%	2.03%	19.02	4.90	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$56.36	35.67%	4.26%	12.97	5.39	41.59%	18.87%
ZTS Zoetis Inc.	$75.14	-45.73%	2.81%	11.76	9.85	83.77%	27.69%
AMGN Amgen Inc.	$414.70	46.88%	2.41%	25.51	19.08	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$750.47	35.09%	0.49%	17.80	2.43	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$109.37	70.62%	0.00%	31.72	91.40	288.13%	24.86%
MCK McKesson Corporation	$962.85	26.60%	0.36%	24.20	-28.76	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$489.96	20.15%	0.00%	29.37	6.39	21.76%	35.00%
CAH Cardinal Health Inc.	$237.45	53.30%	0.86%	32.46	-20.43	-62.92%	0.67%
ARGX argenx SE	$803.12	0.78%	0.00%	15.66	4.13	26.35%	25.62%
HRMY Harmony Biosciences Holdings Inc.	$36.74	38.43%	0.00%	12.88	2.34	18.14%	18.88%
BIIB Biogen Inc.	$228.84	56.13%	0.00%	40.08	1.77	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CLRB - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Cellectar Biosciences

Cellectar Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

30 years

Founded: 1996

2005

Time since IPO - 21 years

11

Employees

Cellectar Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $17.31 million, with shareholders equity totaling $29.87 million.

The company employs approximately 11 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Cellectar Biosciences Inc. reported $- in revenue, generating net income of $-22.32 million.

Key financial metrics include a P/E ratio of -0.78, a price-to-book (P/B) ratio of 0.58, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CLRB.

Market cap

$17.31 million

Net worth

$29.87 million

$29,872,000.00

Assets

$36.64 million

$36,639,000.00

Total Shares Outstanding

12.23 million

12,231,000

Average Daily Trading Volume

$54.52 Thousand

$54,515.36

Sector

Health Care

Industry

Biotechnology

CLRB

CLRB revenue and profits

Financial Results CLRB

DRAG THE FRAME TO SEE MORE DATA

CLRB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$962.85 25,62% (12M)

P/E

24.20

0.36%

ROE

-118.84%

P/BV

-28.76

CAH - Cardinal Health

$237.45 55,85% (12M)

P/E

32.46

0.86%

ROE

-62.92%

P/BV

-20.43

ABBV - AbbVie

$276.61 23,94% (12M)

P/E

77.50

2.47%

ROE

-106.44%

P/BV

-82.49

MRK - Merck & Co.

$142.71 71,41% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$157.00 --6,19% (12M)

P/E

19.02

2.03%

ROE

25.77%

P/BV

4.90

PFE - Pfizer

$28.25 24,16% (12M)

P/E

36.34

6.23%

ROE

5.07%

P/BV

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12M)

P/E

12.97

4.26%

ROE

41.59%

P/BV

5.39

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$962.85 25,62% (12 M)

P/L

24.20

0.36%

ROE

-118.84%

P/VP

-28.76

CAH - Cardinal Health

$237.45 55,85% (12 M)

P/L

32.46

0.86%

ROE

-62.92%

P/VP

-20.43

ABBV - AbbVie

$276.61 23,94% (12 M)

P/L

77.50

2.47%

ROE

-106.44%

P/VP

-82.49

MRK - Merck & Co.

$142.71 71,41% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$157.00 --6,19% (12 M)

P/L

19.02

2.03%

ROE

25.77%

P/VP

4.90

PFE - Pfizer

$28.25 24,16% (12 M)

P/L

36.34

6.23%

ROE

5.07%

P/VP

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12 M)

P/L

12.97

4.26%

ROE

41.59%

P/VP

5.39

Frequently Asked Questions

What is the price of Cellectar Biosciences (CLRB) today?

The current price of Cellectar Biosciences (CLRB) is $1.44. The stock began the year trading around $2.95 and is currently priced at $1.44. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Cellectar Biosciences (CLRB) pay dividends?

Cellectar Biosciences (CLRB) did not pay dividends over the past year.

Is Cellectar Biosciences (CLRB) a good investment?

Cellectar Biosciences (CLRB) is currently trading at $1.44 with a P/E ratio of -0.78. This represents a -60% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -68.96%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cellectar Biosciences (CLRB) stock?

You can buy Cellectar Biosciences (CLRB) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CLRB and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Cellectar Biosciences (CLRB) yield today?

Over the past month, Cellectar Biosciences (CLRB) has returned -37.93% — -68.96% over the past year, and -99.47% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Cellectar Biosciences (CLRB) today at the current price of $1.44 your total investment would be $144.01.

Based on historical performance, the investment would have grown to approximately:

$44.70 after 1 year
$0.76 after 5 years
$0.03 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CLRB

Cellectar Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CLRB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CLRB WITH OTHER STOCK

ABOUT Cellectar Biosciences

Cellectar Biosciences Inc.

United States

30 years

2005

11

PROFIT X PRICE CLRB

Financial Results CLRB

CLRB cash flow

Asset, Revenue and Profit Growth - CLRB

CLRB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions